Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Crowther

Showing results (251-260 of 282) with videos related to

Pageof 29
Sort By:
British Medical Journal|January 24, 1970
L-asparaginase in treatment of acute leukaemia and lymphosarcomaM E Beard, D Crowther, D A Galton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
A randomised trial investigating the dose intensity of primary chemotherapy in patients with ovarian carcinoma: a comparison of chemotherapy given every four weeks with the same chemotherapy given at three week intervalsE Wrigley, A Weaver, G Jayson, et al.
British Journal of Cancer|July 1, 1988
In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patientsM H Bronchud, M R Potter, G Morgenstern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's diseaseJ A Radford, D Crowther, A Z Rohatiner, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancerA Howell, R D Rubens, H Bush, et al.
Lancet (London, England)|August 11, 1984
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancerA Howell, H Bush, W D George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in MelanomaArianna Draghi, Mario Presti, Agnete W P Jensen, et al.
British Medical Journal|March 4, 1978
Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological typeT A Lister, M H Cullen, M E Beard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histologyT A Lister, M H Cullen, R B Brearley, et al.
European Journal of Cancer|November 1, 1980
Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma. (A report of 89 cases with extensive disease from the Manchester Lymphoma Group)G Blackledge, H Bush, J Chang, et al.
Pageof 29

Showing results (251-260 of 282) with videos related to

Sort By:
Pageof 29
British Medical Journal|January 24, 1970
L-asparaginase in treatment of acute leukaemia and lymphosarcomaM E Beard, D Crowther, D A Galton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
A randomised trial investigating the dose intensity of primary chemotherapy in patients with ovarian carcinoma: a comparison of chemotherapy given every four weeks with the same chemotherapy given at three week intervalsE Wrigley, A Weaver, G Jayson, et al.
British Journal of Cancer|July 1, 1988
In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patientsM H Bronchud, M R Potter, G Morgenstern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's diseaseJ A Radford, D Crowther, A Z Rohatiner, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancerA Howell, R D Rubens, H Bush, et al.
Lancet (London, England)|August 11, 1984
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancerA Howell, H Bush, W D George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in MelanomaArianna Draghi, Mario Presti, Agnete W P Jensen, et al.
British Medical Journal|March 4, 1978
Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological typeT A Lister, M H Cullen, M E Beard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histologyT A Lister, M H Cullen, R B Brearley, et al.
European Journal of Cancer|November 1, 1980
Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma. (A report of 89 cases with extensive disease from the Manchester Lymphoma Group)G Blackledge, H Bush, J Chang, et al.
Pageof 29